JUSTIN BURKS: Open Payments
NPI 1518596089 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 21 payments from 10 companies in 2025. Trend: 2023 $120 · 2024 $240 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $175 |
| Insmed, Inc. | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Actelion Pharmaceuticals US, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: FASENRA, Arikayce, GLASSIA, NUCALA, TEZSPIRE, BREZTRI, AIRSUPRA, WINREVAIR.
Industry payments across MO — which companies pay providers there.
